Spinal cord injury: Debating the efficacy of methylprednisolone

Neurosurgery

Volumn 61, Issue , 2007, Pages 30-31

  Harrop, James S ^a  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPREDNISOLONE; PLACEBO; NEUROPROTECTIVE AGENT;

CONFERENCE PAPER; DRUG EFFICACY; HUMAN; INCIDENCE; MOTOR PERFORMANCE; MULTICENTER STUDY (TOPIC); PRIORITY JOURNAL; SENSATION; SPINAL CORD INJURY; STEROID THERAPY; WOUND INFECTION; EVIDENCE BASED PRACTICE; FOOD AND DRUG ADMINISTRATION; INTENSIVE CARE; NONHUMAN; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SELECTION BIAS; SPINAL CORD DECOMPRESSION; SYSTEMATIC REVIEW (TOPIC); TREATMENT DURATION; SPINAL CORD INJURIES;

HUMANS; METHYLPREDNISOLONE; NEUROPROTECTIVE AGENTS; SPINAL CORD INJURIES;

EID: 84920387043     PISSN: 0148396X     EISSN: 15244040     Source Type: Journal    
DOI: 10.1227/NEU.0000000000000391     Document Type: Conference Paper

References (9)

1. Fehlings MG, Vaccaro A, Wilson JR, et al. Early versus delayed decompression for traumatic cervical spinal cord injury: results of the Surgical Timing in Acute Spinal Cord Injury Study (STASCIS). PLos One. 2012;7(2):e32037.
2. Chikawa T, Ikata T, Katoh S, Hamada Y, Kogure K, Fukuzawa K. Preventive effects of lecithinized superoxide dismutase and methylprednisolone on spinal cord injury in rats: transcriptional regulation of inflammatory and neurotrophic genes. J Neurotrauma. 2001;18(1):93-103.
3. Taoka Y, Okajima K, Uchiba M, Johno M. Methylprednisolone reduces spinal cord injury in rats without affecting tumor necrosis factor-alpha production. J Neurotrauma. 2001;18(5):533-543.
4. Akhtar AZ, Pippin JJ, Sandusky CB. Animal studies in spinal cord injury: a systematic review of methylprednisolone. Altern Lab Anim. 2009;37(1):43-62.
5. Bracken MB, Collins WF, Freeman DF. Efficacy of methylprednisolone in acute spinal cord injury. JAMA. 1984;251(1):45-52.
6. Bracken MB, Shepard MJ, Collins WF, et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal cord injury: results of the second National Acute Spinal Cord Injury Study. NEngl J Med. 1990;322(20):1405-1411.
7. Bracken MB, Shepard MJ, Holford TR, et al. Administration of methylprednisolone for 24 or 48 hours or tirilazadmesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study. JAMA. 1997;277(20):1597-1604.
8. Coleman WP, Benzel D, Cahill DW, et al. A critical appraisal of the reporting of the National Acute Spinal Cord Injury Studies (II and III) of methylprednisolone in acute spinal cord injury. J Spinal Disord. 2000;13(3):185-199.
9. Hadley M, Walters B, Grabb P, et al. Guidelines for the Management of acute cervical spine and spinal cord injuries. Neurosurgery. 2002;50(3 suppl):S1-S199.